A global healthcare leader, Novo Nordisk specializes in diabetes care, obesity treatment, and rare blood disorders. Its innovative medications, including insulin and GLP-1 agonists like Ozempic, help manage blood sugar and weight. Patients with type 1 or type 2 diabetes, obesity, and related conditions benefit from these therapies, improving quality of life and reducing complications.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·This Month's Top Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends